Evidence map›Paper›PMID 22752304›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma.

Aadra P Bhatt, Sarah R Jacobs, Alex J Freemerman, Liza Makowski, Jeffrey C Rathmell, Dirk P Dittmer, Blossom Damania

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Glucose-independent human cytomegalovirus replication is supported by metabolites that feed upper glycolytic branches.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Aadra P BhattLineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Sarah R Jacobs
Alex J Freemerman
Liza Makowski
Jeffrey C Rathmell
Dirk P Dittmer
Blossom Damania
UNC Lineberger Comprehensive Cancer CenterDuke Medical Center · USSegeberger Kliniken · DEUniversity of North Carolina at Chapel Hill · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
ART Modulation of Viral Pathogenesis in Oral EpitheliaR01DE018304 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2007 to 2025
$6.9M
Role of KSHV Viral Proteins in Signaling and PathogenesisR01CA096500 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A · 2002 to 2022
$6.0M
INFECTIOUS DISEASE PATHOGENESIS TRAININGT32AI007151 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JULIANO, JONATHAN J · 1985 to 2024
$5.5M
Targeted Therapies for HIV-Associated Kaposi Sarcoma and LymphomaR01CA163217 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLOSSOM A DAMANIA, Dirk P Dittmer · 2011 to 2026
$5.5M
CANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0M
Molecular Biology of Viral Diseases Predoctoral Training GrantT32AI007419 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mark T Heise, CARY A MOODY · 1993 to 2026
$4.7M
Pregnancy, Obesogenic Environments, and Basal-like Breast CancerU01ES019472 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TROESTER, MELISSA A. · 2010 to 2014
$2.3M
Glucose metabolism and cell death in cancerR01CA123350 · NCI · DUKE UNIVERSITY · PI RATHMELL, JEFFREY C. · 2007 to 2011
$1.5M
Macrophage Mitochondrial Stress in Inflammation, Insulin Resistance & ObesityR00AA017376 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAKOWSKI-HAYES, LIZA · 2010 to 2012
$728k
NCI NIH HHS CA096500NCI NIH HHS CA123350NCI NIH HHS CA163217NCI NIH HHS R01 CA096500NCI NIH HHS R01 CA123350NCI NIH HHS R01 CA163217NCI NIH HHS T32 CA009156NCI NIH HHS T32 CA071341NCI NIH HHS T32-CA071341NCI NIH HHS T32-CA09156NIAAA NIH HHS AA017376NIAAA NIH HHS K99 AA017376NIAAA NIH HHS R00 AA017376NIAID NIH HHS T32 AI007151NIAID NIH HHS T32AI007151NIAID NIH HHS T32 AI007419NIAID NIH HHS T32-AI007419NIDCR NIH HHS DE018304NIDCR NIH HHS R01 DE018304NIDDK NIH HHS DK056350NIDDK NIH HHS P30 DK034987NIDDK NIH HHS P30DK034987NIDDK NIH HHS P30 DK056350NIEHS NIH HHS ES019472NIEHS NIH HHS U01 ES019472
6 · The paper itself

Abstract

The metabolic differences between B-NHL and primary human B cells are poorly understood. Among human B-cell non-Hodgkin lymphomas (B-NHL), primary effusion lymphoma (PEL) is a unique subset that is linked to infection with Kaposi's sarcoma-associated herpesvirus (KSHV). We report that the metabolic profiles of primary B cells are significantly different from that of PEL. Compared with primary B cells, both aerobic glycolysis and fatty acid synthesis (FAS) are up-regulated in PEL and other types of nonviral B-NHL. We found that aerobic glycolysis and FAS occur in a PI3K-dependent manner and appear to be interdependent. PEL overexpress the fatty acid synthesizing enzyme, FASN, and both PEL and other B-NHL were much more sensitive to the FAS inhibitor, C75, than primary B cells. Our findings suggest that FASN may be a unique candidate for molecular targeted therapy against PEL and other B-NHL.

Indexed as

4-ButyrolactoneB-LymphocytesComputational BiologyFatty AcidsFatty Acid SynthasesGlycolysisHumansImmunoblottingLymphoma, B-CellLymphoma, Primary EffusionMetabolic Networks and PathwaysModels, BiologicalPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine Kinases4-Butyrolactone4-methylene-2-octyl-5-oxofuran-3-carboxylic acidFatty AcidsFatty Acid SynthasesMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID22752304
PMCPMC3406848
OpenAlexW2067872596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.